This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback